Vai al contenuto principale della pagina
| Autore: |
Marianne Boes
|
| Titolo: |
Application of Antigen Cross-Presentation Research into Patient Care
|
| Pubblicazione: | Frontiers Media SA, 2017 |
| Descrizione fisica: | 1 online resource (124 p.) |
| Soggetto topico: | Medicine and Nursing |
| Soggetto non controllato: | clinical translation |
| cross-presentation | |
| dendritic cell | |
| Immunotherapy | |
| Vaccination | |
| Sommario/riassunto: | The activation of adaptive immune responses requires the processing and presentation of protein antigens to lymphocytes. Especially dendritic cells are effective at display of antigen-derived peptides in the form of immunogenic peptide/MHC complexes to CD4 and CD8-positive T cells, and can stimulate even naive T cells to clonally expand. During the last 40 years, mechanisms that facilitate antigen processing and presentation were clarified, mostly from work in cell lines and mouse models. From mouse-based work, it is now clear that dendritic cells represent a collection of specialized cell subsets that are particularly well endowed to stimulate antigen transport to distinct tissue locations, to transfer antigens between cellular subsets or to trigger T cell responses. Dendritic cell subsets hold great promise for therapeutic application, for example as dendritic cell-based vaccines to bolster immune responses against viruses or malignant growths. Hurdles remain that preclude the efficient application of high quality pre-clinical research into standardized patient care. In this research topic, efforts in dendritic cell research and dendritic cell-based vaccines are discussed, from both pre-clinical and application points of view. |
| Titolo autorizzato: | Application of Antigen Cross-Presentation Research into Patient Care ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910227350003321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |